How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

It's an upgrade worth making, but it comes down to your privacy concerns.

As organizations race to adopt artificial intelligence, the conversation has increasingly shifted from raw model performance ...

The latest generation of AI models are such competent coders, engineers and (soon) scientists that many worry they may be ...

Recursion harnesses AI for large-scale drug discovery, while Summit's betting on a single oncology candidate. How do their ...

The ordinary graphite in pencil lead is proving to be surprisingly multifaceted at the microscale. In a study published in ...